Ionis Pharmaceuticals | IONS - Operating Profit


Ionis Pharmaceuticals reported $-130M in Operating Profit for its fiscal quarter ending in September of 2026.





Operating Profit Change Date
Agios Pharmaceuticals USD -110.55M 527K Jun/2026
Alnylam Pharmaceuticals USD 179.66M 67.06M Sep/2026
Arrowhead Research USD -170.09M 28.83M Jun/2026
Astellas Pharma JPY 132.59B 52.76B Sep/2026
BioCryst Pharmaceuticals USD 98.46M 161.92M Jun/2026
BioMarin Pharmaceutical USD 205.6M 100M Sep/2026
Celltrion KRW 19.31B 6.4B Jun/2026
Cspc Pharmaceutical CNY 206.26M 1.02B Dec/2025
Deva Holding AS TRY 964.87M 240.32M Sep/2023
Divis Laboratories Ltd INR 14.24B 2.95B Sep/2026
Exelixis USD 268.42M 20.01M Sep/2026
Halozyme Therapeutics USD -60.68M 3.04M Sep/2026
Ionis Pharmaceuticals USD -130M 27.71M Sep/2026
Kangmei Pharma CNY -35.26M 24.32M Jun/2026
Knight Therapeutics CAD 6.21M 3.27M Dec/2025
Laboratorios Farma EUR 135.05M 49.84M Dec/2023
Malin Corporation EUR -1.1M 400K Dec/2024
Medical Developments International AUD -36K 444K Dec/2025
Moderna USD 130M 945M Sep/2026
Nektar Therapeutics USD -38.26M 19.17M Mar/2026
Neuren Pharmaceuticals AUD 17.01M 11.56M Dec/2025
Neurocrine Biosciences USD 343M 123.1M Sep/2026
Novartis USD 5.14B 392M Sep/2026
Omeros USD -35.41M 23.75M Sep/2024
OPKO Health USD -25.04M 25.98M Jun/2026
Organigram Holdings CAD 5.33M 15.12M Jun/2026
Ovoca Bio EUR -173K 990K Dec/2025
Pfizer USD 662M 5M Sep/2026
Pharma Mar EUR 7.65M 9.06M Sep/2026
PTC Therapeutics USD 148.98M 103.09M Jun/2026
Qiagen NV USD 141.4M 24.77M Jun/2026
Regeneron Pharmaceuticals USD 1.42B 675.7M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sarepta Therapeutics USD -9.04M 22.33M Sep/2026
Sartorius EUR 179.8M 15.8M Sep/2026
Sino Biopharmaceutical CNY 5.18B 3.32B Jun/2025
Tilray USD -20.01M 9.34M Sep/2025
Ultragenyx Pharmaceutical USD -110M 35M Sep/2026
Vertex Pharmaceuticals USD 1.26B 11.3M Sep/2026
Zealand Pharma A/S -539M 168.05M Mar/2026
Zz Pientze Pharmaceu CNY 222.81M 140.02M Sep/2026